PIKFYVE and melanoma: The average levels of IL24 RNA in patient derived melanomas are significantly greater than in samples of normal skin (Fig. S2C), suggesting that PIKFYVE inhibitors alone will have therapeutic potential against many autophagy‐dependent melanomas.